Immunome, Inc. (IMNM)
NASDAQ·Healthcare·Biotechnology
$24.30
-5.63%
Mkt Cap $2.46B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (14 analysts)
$36.50
Range $33.00 – $40.00
Implied Upside
+50.2%
Consensus $36.50 vs current $24.30
NASDAQ·Healthcare·Biotechnology
$24.30
-5.63%
Mkt Cap $2.46B
Buy
8
Hold
0
Sell
0
Price Target (14 analysts)
$36.50
Range $33.00 – $40.00
+50.2%
Consensus $36.50 vs current $24.30